what is the other name for tirzepatide Lilly's Mounjaro tops GLP-1s some type 2 diabetes patients How the weight loss drug

Dissecting mammalian spermatogenesis using Spatial transcriptomics

I'm feeling so much more confident, healthier and fitter." Related: "Through These Baby Steps, The Gym Did More For My Grief Than I Ever Thought" 20

Overview SLU-PP-332 is a research-grade synthetic peptide developed at Saint Louis University, designed to act as a selective agonist of ERR, a nuclear receptor that regulates mitochondrial biogenesis, fatty acid oxidation, and oxidative phosphorylation

Compared with daily insulin glargine and degludec, once-weekly tirzepatide significantly decreased HbA1c (WMD 1.08%, 95% CI (1.37, 0.78)), 2h-posprandial blood sugar (BS) (WMD 28.19 mg/dL, 95% CI (44.98, 11.41)), pre-meal BS (WMD 11.86 mg/dL, 95% CI (22.83, 0.9)), body weight (WMD 10.61 kg, 95% CI (13.24, 7.97)), systolic blood pressure (WMD 6.47 mmHg, 95% CI (8.32, 4.61)), diastolic blood pressure (WMD 2.30 mmHg, 95% CI (3.05, 1.55)), total cholesterol (WMD 4.78%, 95% CI (7.05, 2.50)), triglyceride (WMD 14.49%, 95% CI (19.55, 9.43)), LDL cholesterol (WMD 5.98%, 95% CI (9.83, 2.13)), and VLDL cholesterol (WMD 14.18%, 95% CI (19.03, 9.33)) and increased HDL cholesterol (WMD 7.13%, 95% CI (9.83, 2.13)), with a lower risk of hypoglycemia defined as BS 70 mg/dL (RR 0.46, 95% CI (0.28, 0.75))

Lidia Mnguez-Alarcn, a reproductive epidemiologist and assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School, noted that the research was conducted only in men with high body mass index and that the benefits may not extend to the broader population

Across these areas, results remain preliminary but encouraging